Replies to post #552447 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Shame, shame to ALL who profit from holding ANY promising cancer treatment up.

Exactly Lorie3168!

Here's one more person you can add to the list: Martin J van den Bent.

27 min. ago

Critical review of the report on the DCvax-L trial: the trial did not meet its prospectively defined endpoint and post-hoc analyses with poorly selected external controls do not replace a proper prospective trial https://t.co/3kJnHYW4P6

— Martin van den Bent (@MartinvdenBent) December 23, 2022

Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?

Neuro-Oncology, noac281, https://doi.org/10.1093/neuonc/noac281
Published: 23 December 2022
https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noac281/6958519?login=false

Importantly, overly positive interpretation of the study data is misleading to patients and must be avoided, as the current data simply do not warrant application of DCVax-L in patients with newly
diagnosed or recurrent glioblastoma. Our mission is not to give more treatments to patients but to deliver treatments that improve outcome, based on solid evidence and not speculation.